However, in Caucasians, no statistically significant changes in CYP2B6 expression in alcoholic liver disease, as well as in hepatitis C virus-induced liver damage and primary sclerosing cholangitis, were observed [23]. This evidence concerns the gene CYP2B6 and sclerosing cholangitis.